Coronavirus Update: Gilead Says 'Inappropriate Characterizations' In Remdesivir Trial Flop Leak
Plus: J&J Finds Manufacturing Partner, AZ To Investigate Heart Complications
• By Scrip Team
Three Phase III readouts are expected in the next few weeks, which should provide a clearer picture on remdesivir 
